SS-31 (also known as Elamipretide, Bendavia, or MTP-131) is a cell-permeable, mitochondria-targeted tetrapeptide that concentrates 1000-5000x in the inner mitochondrial membrane. Developed at the Szeto-Schiller lab at Weill Cornell, it was designed to target cardiolipin — a phospholipid critical for electron transport chain function.
Mitochondrial dysfunction is now recognized as a root cause of aging and age-related disease. As mitochondria deteriorate with age, electron transport becomes less efficient, ATP production drops, and reactive oxygen species (ROS) increase. SS-31 directly addresses this by restoring cardiolipin interactions with cytochrome c, normalizing electron transport and reducing ROS production.
SS-31 has been studied in clinical trials for heart failure, Barth syndrome, age-related macular degeneration, and primary mitochondrial myopathy. It represents one of the most scientifically rigorous approaches to targeting the mitochondrial basis of aging.
Looking for the best vendor deals?
Compare prices across 10+ peptide and anabolic vendors. Find the best quality at the lowest price.
Compare Vendors